Astrana Health, Inc. filed its quarterly report on Form 10-Q with the U.S. Securities and Exchange Commission on August 10, 2026, covering the fiscal quarter ended June 30, 2026.

Key Highlights

  • Shares outstanding: As of August 3, 2026, there were 55,737,168 shares of common stock issued and outstanding, according to the filing.
  • Treasury shares: Of the total shares, 6,132,802 are owned by Allied Physicians of California, a Professional Medical Corporation d.b.a. Allied Pacific of California IPA ("APC"), a consolidated affiliate, and are treated as treasury shares for accounting purposes.
  • Filer status: The company is classified as a large accelerated filer, and is not a smaller reporting company or emerging growth company.
  • Exchange listing: Common stock ($0.001 par value per share) trades under the symbol ASTH on The Nasdaq Stock Market LLC.
  • Material weakness: The filing references forward-looking statements regarding the company's "ability to remediate the material weakness in our internal control over financial reporting."
  • Key programs: The company discloses participation in the ACO REACH Model, the ACO LEAD Model, and the Medicare Shared Savings Program (MSSP), noting that CMS has not reviewed statements about these programs contained in the report.

Astrana Health Q2 2026: Financial Period, Share Count, and Disclosed Considerations

Astrana Health, Inc. (NASDAQ: ASTH), a Delaware corporation headquartered at 1668 S. Garfield Avenue, 2nd Floor, Alhambra, California 91801, submitted its quarterly report covering the period ended June 30, 2026. The filing confirms the company had 55,737,168 shares of common stock issued and outstanding as of August 3, 2026. Of these, 6,132,802 shares held by APC, a consolidated affiliate, are legally issued and outstanding but treated as treasury shares for accounting purposes, as the filing states.

The company disclosed participation in several federal healthcare programs, including the ACO REACH Model, the ACO LEAD Model, and the MSSP. The filing notes explicitly that "the Centers for Medicare and Medicaid Services has not reviewed any statements contained in this report" regarding those programs. The filing also includes condensed consolidated financial statements for the three and six months ended June 30, 2026, along with management's discussion and analysis of financial condition and results of operations.

Among the forward-looking topics the company identified in its cautionary language are statements regarding its ability to remediate a previously disclosed material weakness in internal control over financial reporting, potential changes to Medicaid and Medicare programs, and the impact of cybersecurity breaches. The filing states these forward-looking statements "present our estimates and assumptions only as of the date of this Quarterly Report on Form 10-Q and are subject to change." The company noted it is not a shell company, and it confirmed compliance with electronic filing requirements under Rule 405 of Regulation S-T.

What Was Disclosed

Astrana Health filed its Form 10-Q for the quarter ended June 30, 2026, reporting 55,737,168 shares outstanding as of August 3, 2026, confirming its large accelerated filer status, and disclosing ongoing participation in federal value-based care programs.